(Q42993036)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Arturo Chiti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Giovanna Pepe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Wim Oyen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Irene Virgolini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jamshed B Bomanji

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Richard P Baum

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Stefano Fanti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Michael Gabriel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Nikolaos D Papathanasiou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Clemens De Cristoforo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

number of pages

7

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

2004-2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20596866%20AND%20SRC:MED&resulttype=core&format=json

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

6 February 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-010-1512-3

68Ga-labelled DOTA-derivatised peptide ligands

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-010-1512-3

Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide

21 January 2018

1 reference

12 December 2020

Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours

1 reference

12 December 2020

Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.

1 reference

12 December 2020

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.

1 reference

12 December 2020

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours

1 reference

12 December 2020

Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET.

1 reference

12 December 2020

Radiolabelling, quality control and radiochemical purity assessment of the Octreotide analogue 68Ga DOTA NOC.

1 reference

12 December 2020

A fully automated synthesis for the preparation of 68Ga-labelled peptides.

1 reference

12 December 2020

Radiolabelling DOTA-peptides with 68Ga

1 reference

12 December 2020

Nuclear medicine imaging of neuroendocrine tumours

1 reference

12 December 2020

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting

1 reference

12 December 2020

68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid

1 reference

12 December 2020

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

1 reference

12 December 2020

(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma

1 reference

12 December 2020

Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.

1 reference

12 December 2020

Evaluation of Positron Emission Tomography Imaging Using [68Ga]-DOTA-D Phe1-Tyr3-Octreotide in Comparison to [111In]-DTPAOC SPECT. First Results in Patients with Neuroendocrine Tumors

1 reference

12 December 2020

Radionuclide imaging of neuroendocrine tumours: biological basis and diagnostic results

1 reference

12 December 2020

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

1 reference

12 December 2020

68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors

1 reference

12 December 2020

Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours

1 reference

12 December 2020

Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors

1 reference

12 December 2020

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors

1 reference

12 December 2020

Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors

1 reference

12 December 2020

Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors

1 reference

12 December 2020

Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma

1 reference

12 December 2020

Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals

1 reference

12 December 2020

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

12 December 2020

Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.

1 reference

12 December 2020

Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan).

1 reference

12 December 2020

Processing of generator-produced 68Ga for medical application.

1 reference

12 December 2020

Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours

1 reference

12 December 2020

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide

1 reference

12 December 2020

(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours.

1 reference

12 December 2020

Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management

1 reference

12 December 2020

Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity

1 reference

12 December 2020

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

1 reference

12 December 2020

68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors

1 reference

12 December 2020

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

1 reference

12 December 2020

68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy

1 reference

12 December 2020

Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.

1 reference

12 December 2020

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

1 reference

12 December 2020

Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningioma

1 reference

12 December 2020